Sign In
Buy ALK
$42.69
+0.82 (+1.96%)
At Close: Jun 04, 2026
Why Alaska Air Blasted Higher Today
01:26pm, Tuesday, 10'th Dec 2024
Shares of Alaska Air Group (ALK 12.72%) rallied as much as 17.9% on Tuesday, before settling into a 13.1% gain as of 12:26 p.m. ET.
Alaska Air Stock Flies High on Boosted Guidance and $1 Billion Share Buyback Program
12:09pm, Tuesday, 10'th Dec 2024
The company lifted its fiscal 2025 earnings outlook and anticipates ‘unprecedented' growth.
Alaska Airlines CEO on flight expansions and strong earnings results
11:14am, Tuesday, 10'th Dec 2024
Ben Minicucci, Alaska Airlines CEO, joins 'Squawk on the Street' to discuss the company's quarterly earnings results, if Alaska is a new global carrier, and much more.
Alaska Air Group Stock Soars on New Strategic Plan, Raised Outlook
11:01am, Tuesday, 10'th Dec 2024
Shares of Alaska Air Group (ALK) flew 14% higher Tuesday morning after the Alaska Airlines parent unveiled its strategic plan aimed at creating $1 billion in incremental profit in three years. The car
American Airlines Upgrade, Alaska's Growth Plan Send Shares Higher
08:19am, Tuesday, 10'th Dec 2024
American Airlines stock upgraded on improving Q4 outlook. Alaska Air rallies on strategic growth plan, new global hub, strong guidance.
Alaska Air is latest airline to boost guidance on strong holiday travel demand
06:49am, Tuesday, 10'th Dec 2024
Alaska Airlines Inc.'s stock was up 1.6% early Tuesday, after the regional carrier joined rivals in raising its fourth-quarter guidance as revenue rose more than expected and costs came down.
Alaska Airlines plans new nonstop flights to Japan, Korea in $1 billion postmerger profit push
06:00am, Tuesday, 10'th Dec 2024
Alaska Airlines plans to launch nonstop flights to Tokyo and Seoul from Seattle next year. The carrier closed its acquisition of Hawaiian Airlines in September, which gave it access to wide-body airpl
Alaska Air Group to unlock significant short- and long-term value creation to drive double digit margins of 11-13% and EPS to at least $10 by 2027; acquisition synergy estimates increased to at least
New Year, New Sponsor: Presenting Alaska Airlines New Year's at the Needle
11:30am, Friday, 06'th Dec 2024
The West Coast's beloved New Year's Eve drone, fireworks, and light show returns with a new sponsor and even bigger broadcast. SEATTLE , Dec. 6, 2024 /PRNewswire/ -- The Space Needle is proud to prese
American Airlines price target raised to $18 from $16 at Barclays
05:52am, Friday, 06'th Dec 2024
Barclays raised the firm's price target on American Airlines to $18 from $16 and keeps an Equal Weight rating on the shares. The firm sees a bullish setup for the North American airlines in 2025 as yi
Alaska Air Group Digital Transformation Strategy 2024 - Accelerators, Incubators and Other Innovation Programs
04:26am, Friday, 06'th Dec 2024
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Alaska Air Group Inc. - 2024" company profile has been added to ResearchAndMarkets.com's offering.
Alaska Airlines takes center stage as the official airline of Coachella and Stagecoach Festivals
11:00am, Thursday, 05'th Dec 2024
With the most flights to Palm Springs, your journey to music, style and unforgettable memories this April starts with us SEATTLE , Dec. 5, 2024 /PRNewswire/ -- Get ready for a first class festival exp
Alaska Airlines flights grounded in a ‘significant disruption' on Cyber Monday
01:50pm, Tuesday, 03'rd Dec 2024
A technology issue at Alaska Airlines resulted in the temporary grounding of flights in Seattle on Monday morning and problems into the afternoon for people trying to book flights on its website, the
Alaska Airlines IT issue grounds flights, disrupts Cyber Monday orders
10:06am, Tuesday, 03'rd Dec 2024
Seattle-based Alaska Airlines is recovering Tuesday after an IT issue grounded flights at its hub airport and stopped passengers from making online bookings.
Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
07:30am, Tuesday, 03'rd Dec 2024
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial
